Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05265897 · ClinicalTrials.gov registry record · NA
Improving Implementation of Lung Cancer Screening in Diverse Populations II
A NA study, sponsored by University of Washington.
- Completed
- Registry status
- NA
- Development phase
- 230
- Enrollment target
NCT05265897 is a NA study that has completed, run by University of Washington. The registered enrollment target is 230 participants.
The verdict
NCT05265897, a NA study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- NA
- Development phase
- 230 participants
- Enrollment target
Study Summary
This project assesses the feasibility, appropriateness, and acceptability of a "Commonly Asked Questions after Lung Cancer Screening" (CAQ) informational document that the investigators created, resulting from patient and provider discussion in focus groups and interviews. If effective, the CAQ may be a new tool to help improve patient understanding of LCS results and adherence to follow-up recommendations.
Interventions
- OTHER CAQ
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 230 participants |
| Start Date | 2020-12-01 |
| Est. Completion | 2021-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05265897
The ClinicalTrials.gov registry entry for NCT05265897 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 230 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CAQ is the first listed.
NCT05265897 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05265897 about?
NCT05265897 is a clinical study titled "Improving Implementation of Lung Cancer Screening in Diverse Populations II". This project assesses the feasibility, appropriateness, and acceptability of a "Commonly Asked Questions after Lung Cancer Screening" (CAQ) informational document that the investigators created, resulting from patient and provider discussion in focus groups and interviews. If effective, the CAQ may ...
What is the current status of trial NCT05265897?
This trial is currently completed. It is a NA study. The enrollment target is 230 participants. The study started on 2020-12-01. Estimated completion is 2021-06-30.
What interventions are being tested in trial NCT05265897?
The interventions under investigation include: CAQ (OTHER).
Who is sponsoring clinical trial NCT05265897?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.